Galera Therapeutics, Inc. (GRTX)

Galera Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	18.26	4.27	19.86	15.87	18.36
Short-Term Investments	0	27.33	51.36	56.9	93.93
Cash & Cash Equivalents	18.26	31.6	71.22	72.78	112.29
Cash Growth	-42.22%	-55.63%	-2.14%	-35.19%	37.75%
Other Current Assets	3.37	6.94	6.18	5.15	5.28
Total Current Assets	21.63	38.54	77.39	77.93	117.57
Property, Plant & Equipment	1.28	0.48	0.82	1.55	1.75
Goodwill	0.88	0.88	0.88	0.88	0.88
Intangible Assets	2.26	2.26	2.26	2.26	2.26
Other Long-Term Assets	0.09	1.88	1.96	1.48	0.92
Total Long-Term Assets	4.51	5.5	5.92	6.17	5.81
Total Assets	26.14	44.04	83.31	84.1	123.38
Accounts Payable	1.38	3.58	5.04	5.15	3.95
Current Debt	0.13	0.04	0.26	0.24	0.3
Other Current Liabilities	3.45	9.75	7.63	8.58	5.45
Total Current Liabilities	4.96	13.38	12.94	13.97	9.69
Long-Term Debt	151.05	139.64	0.04	0.3	0.53
Other Long-Term Liabilities	1.32	0.2	128.34	63.72	43.54
Total Long-Term Liabilities	152.37	139.84	128.38	64.01	44.07
Total Liabilities	157.33	153.22	141.32	77.98	53.77
Total Debt	152.3	0.04	0.3	0.53	0.83
Debt Growth	346034.09%	-85.43%	-43.45%	-35.74%	-
Common Stock	0.05	0.03	0.03	0.03	0.03
Retained Earnings	-437.41	-378.32	-316.1	-235.57	-161.35
Comprehensive Income	0	-0.02	-0.01	0.01	0.04
Shareholders' Equity	-131.19	-109.18	-58	6.12	69.61
Total Liabilities and Equity	26.14	44.04	83.31	84.1	123.38
Net Cash / Debt	-134.04	31.55	70.92	72.24	111.46
Net Cash / Debt Growth	-	-55.51%	-1.84%	-35.19%	36.73%
Net Cash Per Share	-3.01	1.16	2.75	2.90	4.49
Working Capital	16.67	25.16	64.46	63.96	107.88
Book Value Per Share	-2.94	-4.03	-2.25	0.25	2.81

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.